Benjamin Brooks

4.0k citations
19 papers · 3.3k · 2 hit papers · h-index 12

Impact in

Papers in

    • Peripheral Neuropathies and Disorders 5
    • Myasthenia Gravis and Thymoma 4
    • Botulinum Toxin and Related Neurological Disorders 1
    • Multiple Sclerosis Research Studies 5

Benjamin Brooks

17 papers receiving 3.1k citations

Benjamin Brooks's Hit Papers

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017 · 622 citations
6220+10+20Years since publication50010001.5k

Peers

Benjamin Brooks
Comparison fields: 5 of 96
  • Pathology and Forensic Medicine 2.0k
  • Neurology 1.4k
  • Rheumatology 475
  • Immunology 627
  • Developmental Neuroscience 88
Replace Csilla Rózsa with:
Csilla Rózsa Hungary
Sandrine Wiertlewski France
Élisabeth Maillart France
Nicole Mairon France
Gavin Giovannoni United Kingdom
L. P. Weiner United States
HP Hartung Germany
Akiyuki Uzawa Japan
Mikael Cohen France
James R. Overell United Kingdom
Benjamin Brooks relative to Csilla Rózsa Hungary Csilla Rózsa's profile →
Citations per field
00.5×1.5×1.8×
Csilla Rózsa · 1×
Citations per year

Countries citing papers authored by Benjamin Brooks

Since Specialization
Citations

This map shows the geographic impact of Benjamin Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Brooks more than expected).

Fields of papers citing papers by Benjamin Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Brooks. The network helps show where Benjamin Brooks may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Brooks Line = papers co-authored together Benjamin Brooks links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Hit paper breakdown →
19951603
2
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Hit paper breakdown →
2017622
3 1998430
4 2000192
5 2000172
6 202066
7 200349
8 201946
9 197738
10 201026
11 201021
12 201919
13 200712
14 19777
15 20183
16 19963
17 19942
18 20250
19 20250

About Benjamin Brooks

Benjamin Brooks is a scholar working on Neurology, Pathology and Forensic Medicine, Epidemiology, Infectious Diseases and Sensory Systems, having authored 19 papers that have together received 3.3k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (5 papers), Peripheral Neuropathies and Disorders (5 papers), Myasthenia Gravis and Thymoma (4 papers), Synthetic Organic Chemistry Methods (1 paper), Botulinum Toxin and Related Neurological Disorders (1 paper), Nematode management and characterization studies (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (2.0k citations), Neurology (1.4k citations), Rheumatology (475 citations), Immunology (627 citations) and Developmental Neuroscience (88 citations). Benjamin Brooks has collaborated with scholars based in United States, Russia and United Kingdom. Frequent co-authors include Robert P. Lisak, Corey C. Ford, John W. Rose, Lawrence W. Myers, HILLEL S. PANITCH, J. S. Wolinsky, L. P. Weiner, K. P. Johnson, Timothy R. Vollmer and Jonathan M. Goldstein. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, The Journal of Membrane Biology, Quality of Life Research and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact